Contract facts
FederalEXECUTIVE RECRUITMENT BPA is a federal award for Fda Office Of Acq Grant Svcs held by Ae Strategies, LLC. Estimated value $8.5M ($19M obligated). Current period of performance ends Sep 15, 2027 (potential Sep 29, 2028). Last award drew 1 bidder. Place of performance: MCLEAN VA. Related solicitation 75F40124Q00267.
Recompete timing
PublicCurrent PoP ends Sep 15, 2027 (391 days remaining). Agencies typically plan 12–18 months ahead — position before the PoP clock runs out.
Incumbent footprint
Public recordAe Strategies, LLC — $23.4M obligated across 40 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75F40124F19009?
75F40124F19009 (Executive recruitment BPA) is a Fda Office Of Acq Grant Svcs award with a potential value of $8.5M, currently held by Ae Strategies, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75F40124F19009?
Fda Office Of Acq Grant Svcs awarded 75F40124F19009 to Ae Strategies, LLC (potential $8.5M).
Who is the incumbent on 75F40124F19009?
Ae Strategies, LLC is the incumbent with $23.4M across 40 related awards in SCOUT’s public footprint. The current period of performance ends Sep 15, 2027.
When does Ae Strategies, LLC’s 75F40124F19009 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 15, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.
